Domingo, C, Crespo-Lessmann, A, McGarvey, L. A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.07.020. PMID:40887323. IF:9.200(Q1/1D).

Casanova, C, Gonzalez-Dávila, E, De Torres, JP, Cabrera, C, Cosio, BG, O'Donnel, DE, Martínez-Gonzalez, C, Solanes, I, Fuster, A, Gotera, C, Marin, A, Amado, C, Iscar, M, Marin, JM, Neder, JA, Feu, N, Soriano, JB, López-Campos, JL, Divo, M, Peces-Barba, G, Celli, BR. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.05.004. PMID:40447521. IF:9.200(Q1/1D).

Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez-Alvarez, M, Villar, J, Carrizosa, X, Quero, S, Gabaldon, T, Willis, JR, Saus, E, Gea, J, Santos, S, Camps, P, Agusti, A, Monso, E, Sibila, O, Faner, R. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine. 2026; 123DOI:10.1016/j.ebiom.2025.106099. PMID:41483682. IF:10.800(Q1/1D).

Betancor, D, Rial, MJ, Olaguibel, JM, Del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cárdaba, B, Cañas, JA, Domínguez-Ortega, J, Crespo-Leshman, A, Cruz, MJ, de la Fuente, AG, González-Barcalai, FJ, Luna-Portac, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Plaza, V, Quirce, S, Soto-Retes, L, Valverde-Monge, M, Sastre, J. Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.06.016. PMID:40707281. IF:9.200(Q1/1D).

Rivas, DD, Martinez-Moragon, E, Plaza, V, Serrano, CC, Benchimol, C, Flores, HI, Sánchez-Cuéllar, S, Martinez-Pitarch, MD, Aracil, CF, Alonso, AT, Rebollo, JCS, Gambasica, ZV, Campos, RMD, Mulato, PT, Gimeno, IE, Laorden, D, Arismendi, E, Malanda, NM, Damia, AD, Galvan, MF, Dávila, I, Bobo, JOD, Cosio, BG, de Llano, LAP. Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.04.003. PMID:40348717. IF:9.200(Q1/1D).

Pascual, MB, Zapata-Huizi, JJ, Ramos, D, Francesqui, J, Alsina-Restoy, X, Hernández-González, F, Sellares, J. Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 46(06)DOI:10.1055/a-2741-2030. PMID:41213628. IF:2.700(Q2/5D).

Moreno, BR, Benitez, ID, Erro, M, Burgos, J, Sayés, A, Garcia-Urrestarazu, EJ, Pou, C, Castan, RA, Navarro, A, Fuentes, AMD, Lakhani, JS, Juez-Garcia, I, Manzano, C, Santisteve, S, Morales, A, Monge, A, Moncusi-Moix, A, Sánchez-Cucó, A, Alcaide, AB, de-Torres, JP, Barbé, F, Suarez-Cuartin, G, de la Rosa, D, González, J. Phenotype Analysis of Chronic Bronchial Infection Patients on Inhaled Antibiotic Therapy: A Multicentre Retrospective Cohort Study in Spain (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(9)DOI:10.1016/j.arbres.2025.04.008. PMID:40350352. IF:9.200(Q1/1D).

Franquet, T, Brenes, JM, Radike, M, Giménez, A, Domingo, P. Imaging of Immunodeficiency-Associated Lymphoproliferative Disorders. SEMINARS IN ULTRASOUND CT AND MRI. 2025; 46(4)DOI:10.1053/j.sult.2025.06.001. PMID:40543829. IF:1.900(Q3/6D).

Domingo, P, Stapleton, JT. The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization. AIDS. 2026; 40(1)DOI:10.1097/QAD.0000000000004369. PMID:41489321. IF:3.100(Q2/4D).

Timiryasova, A, Greenberg, L, Domingo, P, Tarr, PE, Egle, A, Martin, C, Mussini, C, Wit, F, Cingolani, A, Lehmann, C, Castagna, A, Petoumenos, K, Sabin, CA, Bonnet, F, Lundgren, J, Bottanelli, M, Hosein, S, Carlander, C, Amstutz, A, Grabmeier-Pfistershammer, K, Garges, H, Marongiu, A, Young, LA, Peters, L, Ryom, L. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Cancers. 2025; 17(24)DOI:10.3390/cancers17244000. PMID:41463249. IF:4.400(Q2/3D).

Domingo, P, Prieto, P, Pons, L. A plague like no other: beyond the buboes in Thucydides' account of the Plague of Athens. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(10)DOI:10.1016/j.cmi.2025.05.001. PMID:. IF:8.500(Q1/1D).

Monforte, A, Imaz, A, Ferrer, J, Piatti, C, Molero, M, Rodríguez, A, Stable, CE, Navarro, M, Prieto, P, Domingo, P, Crespo, M, Güerri-Fernández, R, Moltó, J, Navarro, J. Efficacy and tolerability of BIC/TAF/FTC in people with HIV and solid and hematological neoplasms: a multicenter observational study (BIKONCO study). HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Peters, L, Bannister, W, Sridhar, G, Gardizi, M, van Frankenhuijsen, M, De Scheerder, MA, Johansen, IS, Viard, JP, Duvivier, C, Bogner, J, Degen, O, Castagna, A, Staub, T, Martinez, E, Domingo, P, Moreno, S, Reikvam, DH, Parczewski, M, Knysz, B, Shivkar, Y, Brown, K, van Wyk, J, Vannappagari, V. High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Masia, M, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Garcia-Fraile, L, Blanco, JL, Ryan, P, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Virological non-inferiority and lower weight gain with DTG/3TC versus BIC/FTC/TAF: 96-week final results from the PASO-DOBLE (GeSIDA 11720) randomised, multicentre, openlabel, non-inferiority trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Berenguer, J, Ryan, P, Lutz, T, Martin-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, J, De los Santos, I, Esser, S, Morano, LE, López, I, Valencia, J, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Fariñas, C, Raczynska, A, Voit, F, Qurishi, N, Noe, S, Reus, S, Khaykin, P, Schneeweiss, S, Wandeler, G, Boyd, A, De Miguel, M, Bellón, JM, Parczewski, M, Rockstroh, J. Hepatocellular carcinoma screening in HIV/HBV coinfected individuals: insights from Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Ryan, P, Berenguer, J, Lutz, T, Martín-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, JJ, De los Santos, I, Esser, S, Morano, LE, López, I, Cuevas, G, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Armiñanzas, C, Raczynska, A, Voit, F, Qurishi, N, Christensen, S, Szymczak, A, Hlebowicz, M, Schwarze-zander, C, Jessen, A, Boyd, A, De Miguel, M, Bellon, JM, Parczewski, M, Rockstroh, J. Prevalence and factors associated with liver cirrhosis in people with HIV and chronic hepatitis B: a cross-sectional study in Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Quesada-López, T, Mestres-Arenas, A, Domingo, P, Prieto, P, Mur, I, Pérez, JAH, Guimaraes, MP, Villarroya, J, Gutiérrez, MD, Mateo, MG, Domingo, JC, Planavila, A, Villarroya, F, Giralt, M, Cereijo, R. Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV. EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; 1003DOI:10.1016/j.ejphar.2025.177996. PMID:40714072. IF:4.700(Q1/2D).

Scévola S, Niubó J, Domingo P, Verdejo G, Curran A, Diaz-Brito V, Peñafiel J, Tiraboschi J, Morenilla S, Garcia B, Soriano I, Podzamczer D, Imaz A. Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.. JOURNAL OF INFECTIOUS DISEASES. 2023; 228(7)DOI:10.1093/infdis/jiad304. PMID:37526315. IF:(Q/D).

González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E. Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad247. PMID:37539492. IF:3.900(Q1/3D).

Lasaga M, Río P, Vilas-Zornoza A, Planell N, Navarro S, Alignani D, Fernández-Varas B, Mouzo D, Zubicaray J, Pujol RM, Nicoletti E, Schwartz JD, Sevilla J, Ainciburi M, Ullate-Agote A, Surrallés J, Perona R, Sastre L, Prosper F, Gomez-Cabrero D, Bueren JA. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.. HAEMATOLOGICA. 2023; 108(10)DOI:10.3324/haematol.2022.282418. PMID:37021532. IF:10.100(Q1/2D).